CA2055433A1 - Method of treatment of hepatitis - Google Patents

Method of treatment of hepatitis

Info

Publication number
CA2055433A1
CA2055433A1 CA002055433A CA2055433A CA2055433A1 CA 2055433 A1 CA2055433 A1 CA 2055433A1 CA 002055433 A CA002055433 A CA 002055433A CA 2055433 A CA2055433 A CA 2055433A CA 2055433 A1 CA2055433 A1 CA 2055433A1
Authority
CA
Canada
Prior art keywords
dideoxycytidine
administered
dna
hepatitis
ddc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002055433A
Other languages
English (en)
French (fr)
Inventor
Jay H. Hoofnagle
Samuel Broder
Hiroaki Mitsuya
Robert Yarchoan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2055433A1 publication Critical patent/CA2055433A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
CA002055433A 1989-05-15 1990-05-15 Method of treatment of hepatitis Abandoned CA2055433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35151989A 1989-05-15 1989-05-15
US351,519 1989-05-15
PCT/US1990/002685 WO1990014079A1 (en) 1989-05-15 1990-05-15 Method of treatment of hepatitis

Publications (1)

Publication Number Publication Date
CA2055433A1 true CA2055433A1 (en) 1990-11-16

Family

ID=23381258

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002055433A Abandoned CA2055433A1 (en) 1989-05-15 1990-05-15 Method of treatment of hepatitis

Country Status (5)

Country Link
EP (1) EP0472595A4 (ja)
JP (1) JPH04501854A (ja)
AU (1) AU5659990A (ja)
CA (1) CA2055433A1 (ja)
WO (1) WO1990014079A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DE4110977A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB9109506D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
NZ216172A (en) * 1985-05-15 1989-08-29 Wellcome Found Nucleosides and pharmaceutical compositions
WO1987001283A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxycytidine
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物

Also Published As

Publication number Publication date
EP0472595A1 (en) 1992-03-04
WO1990014079A1 (en) 1990-11-29
JPH04501854A (ja) 1992-04-02
AU5659990A (en) 1990-12-18
EP0472595A4 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
US5246924A (en) Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
CN100528173C (zh) 4′-取代的核苷
KR100854398B1 (ko) 베타-ｌ-2'-데옥시-뉴클레오사이드를 이용한 델타형 간염바이러스 감염의 치료방법
US6787526B1 (en) Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
CN1195526C (zh) 含对映体纯β－D－二氧戊环核苷的药物产品
US7173017B1 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US20050004053A1 (en) Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
JP2540576B2 (ja) 抗レトロウイルスおよびｂ型肝炎剤
JPS63290895A (ja) 抗ウイルスヌクレオシド
KR20020097384A (ko) 기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
EP1284720B1 (en) L-fmau for the treatment of hepatitis delta viral infection
WO1996001115A1 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US5039667A (en) Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
CA2055433A1 (en) Method of treatment of hepatitis
AU623341B2 (en) Antiviral therapy for hepatitis b
EP0679160B1 (en) Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
AU5832990A (en) Method of treatment of hepatitis
PT1382343E (pt) Terapia de combinação para tratamento do vírus da hepatite b
WO1992016215A1 (en) Use of 3'-azido-2',3'-dideoxyguanosine for the treatment of hepatitis b
KR970011386B1 (ko) 1-(2'-데옥시-2'-플루오로-베타-d-아리비노-푸라노실)-5-에틸우라실을 이용한 간염 비루스 감염질환의 치료방법 및 치료용 조성물
JPS61257925A (ja) 抗ウイルスヌクレオシド
US6329350B1 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
Lofgren et al. 2 ‘, 3’‐dideoxy‐3 ‘‐fluoroguanosine inhibits duck hepatitis B virus in vivo
AU2005232286A1 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
JPS63107921A (ja) ウイルス複製阻害剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead